Vital Signs — Wednesday, October 21, 2026
"Difficulties strengthen the mind, as labor does the body." — Seneca, Letters to Lucilius
(A rough day at the clinic builds the same muscle as a rough workout: resilience.)
Editor's Pick
- Zoetis Receives FDA Approval for Convenia® RTU for Dogs (cefovecin injectable suspension), Helping More Medium and Large Dogs Access Single-Injection Treatment — The FDA approved a concentrated, ready-to-use Convenia formulation that delivers up to 14 days of antibiotic therapy in one small-volume injection; why it matters: with only 27% of owners dosing oral antibiotics on schedule, this is a compliance-first skin-infection option for larger dogs, available Q1 2027.
By the Numbers
- (1.3)% — year-over-year change in U.S. same-store clinical visits in Q2 2026, the third straight year of declines, per IDEXX filings compiled by VetValue — takeaway: if your visit count is flat, you're already beating the market; growth now comes from what happens inside each visit, especially diagnostics.
In the Journals
- Functional Peptides Target Veterinary Osteoarthritis, but Clinical Evidence — A 2026 narrative review finds oral collagen peptides show encouraging signals for dog and horse OA, but concludes no peptide therapy yet qualifies as truly disease-modifying — for now it's an adjunct, not a replacement for multimodal care.
- A new hope for dogs with dementia: Researchers explore gene therapy — USF Health researchers are advancing a one-time gene therapy for canine cognitive decline that delivers a protective protein to brain cells — existing dog-dementia treatments only manage symptoms, so this is one to watch for senior-pet practice.
- Zoetis Receives FDA Approval for Convenia® RTU for Dogs (cefovecin injectable suspension), Helping More Medium and Large Dogs Access Single-Injection Treatment — The more concentrated formulation delivers the same cefovecin dose in a smaller volume than the 2008 original, making single-injection therapy practical for dogs of all sizes — expected in clinics Q1 2027.
The Business End
- Veterinary Industry Trends: Fewer Visits, Bigger Tickets — Mining ~950 SEC filings, VetValue finds the visits being lost are mostly wellness, while Zoetis says price increases that outpaced inflation are making owners "more selective" — their prescription: grow revenue per visit through diagnostics, senior care plans, and wellness enrollment instead of annual fee hikes.
The Fine Print
- Washington Ruling Examines Veterinary Liability Outside the Clinic — A Washington appeals court ruled that the absence of a VCPR doesn't automatically defeat a veterinary-negligence claim when a vet used veterinary training and prescription drugs on someone else's animals — a caution flag for any vet treating animals outside a formal client relationship.
The Feel-Good Finish
- Rescue Dog Punished for Being 'Too Loud' Now Has a Home Where He Can Sing His Heart Out — Petey the American Bulldog was frightened into silence at the shelter; now he's recovering from knee surgery and belting out songs from the back seat while his mom happily sings along.
- This Poor Dog Was Surrendered for Euthanasia, but Her Rescuers Gave Her a Brand-New Life — Surrendered for euthanasia with a neglected 15-pound tumor, Hattie had the growth removed by the Vet Ranch team and went from shelter surrender to a wonderful forever home.
Know an independent practice owner? Forward this.